[{"address1": "Philip Heymans Alle 3", "city": "Hellerup", "zip": "2900", "country": "Denmark", "phone": "45 33 26 83 83", "website": "https://www.bavarian-nordic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, Finland, Netherlands, Switzerland, Sweden, Taiwan, Saudi Arabia, Belgium, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.", "fullTimeEmployees": 1738, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul John Chaplin MSc, Ph.D.", "age": 58, "title": "CEO & President", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3695891, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henrik  Juuel M.Sc.", "age": 60, "title": "CFO & Executive VP", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1699820, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Thirsk M.Sc.", "age": 57, "title": "Executive VP & COO", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rolf Sass Sorensen", "title": "Vice President of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nicole  Seroff", "title": "Vice President Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Christophe  May M.B.A., Pharm.D.", "age": 58, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.bavarian-nordic.com/investor.aspx", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.31, "open": 10.05, "dayLow": 10.05, "dayHigh": 10.05, "regularMarketPreviousClose": 10.31, "regularMarketOpen": 10.05, "regularMarketDayLow": 10.05, "regularMarketDayHigh": 10.05, "exDividendDate": 1585267200, "payoutRatio": 0.0, "beta": 1.121, "trailingPE": 6.4437504, "volume": 2, "regularMarketVolume": 2, "averageVolume": 3400, "averageVolume10days": 1580, "averageDailyVolume10Day": 1580, "bid": 10.23, "ask": 10.29, "bidSize": 2360, "askSize": 860, "marketCap": 2442452480, "fiftyTwoWeekLow": 6.595, "fiftyTwoWeekHigh": 13.0, "allTimeHigh": 14.6, "allTimeLow": 6.595, "priceToSalesTrailing12Months": 0.354653, "fiftyDayAverage": 10.09342, "twoHundredDayAverage": 10.09516, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -2037453568, "profitMargins": 0.35502, "floatShares": 78091428, "sharesOutstanding": 234809649, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 2.0000001e-05, "impliedSharesOutstanding": 236901289, "bookValue": 26.228172, "priceToBook": 0.3930888, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 14.503, "netIncomeToCommon": 2444983040, "trailingEps": 1.6, "enterpriseToRevenue": -0.296, "enterpriseToEbitda": -0.841, "52WeekChange": 0.16628957, "SandP52WeekChange": 0.18594909, "quoteType": "EQUITY", "currentPrice": 10.31, "recommendationKey": "none", "totalCash": 2978458112, "totalCashPerShare": 38.054, "ebitda": 2423385088, "totalDebt": 134042000, "quickRatio": 2.353, "currentRatio": 3.837, "totalRevenue": 6886879232, "debtToEquity": 1.019, "revenuePerShare": 29.008629, "returnOnAssets": 0.07782, "returnOnEquity": 0.20507999, "grossProfits": 3741314048, "freeCashflow": -1852499200, "operatingCashflow": 3132225024, "earningsGrowth": 14.222, "revenueGrowth": 0.317, "grossMargins": 0.54325, "ebitdaMargins": 0.35187998, "operatingMargins": 0.19195999, "financialCurrency": "DKK", "symbol": "BVNRY", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": false, "customPriceAlertConfidence": "LOW", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 3400, "fiftyTwoWeekLowChange": 3.7150006, "fiftyTwoWeekLowChangePercent": 0.5633057, "fiftyTwoWeekRange": "6.595 - 13.0", "fiftyTwoWeekHighChange": -2.6899996, "fiftyTwoWeekHighChangePercent": -0.20692304, "fiftyDayAverageChange": 0.21658039, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1723728600000, "cryptoTradeable": false, "fiftyTwoWeekChangePercent": 16.628956, "dividendDate": 1586131200, "earningsTimestampStart": 1755860340, "regularMarketChange": 0.0, "regularMarketDayRange": "10.05 - 10.05", "earningsTimestampEnd": 1755860340, "earningsCallTimestampStart": 1746792000, "earningsCallTimestampEnd": 1746792000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 1.6, "marketState": "CLOSED", "regularMarketChangePercent": 0.0, "regularMarketPrice": 10.31, "corporateActions": [], "regularMarketTime": 1767992400, "exchange": "PNK", "messageBoardId": "finmb_7687618", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChangePercent": 0.021457583, "twoHundredDayAverageChange": 0.21484089, "twoHundredDayAverageChangePercent": 0.021281574, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "shortName": "Bavarian Nordic A/S", "longName": "Bavarian Nordic A/S", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]